Artist Miguel Bustos was a finalist in a prestigious illustration prize for his work last year on IBEC’s Anniversary Book, ’10 anys d’impacte’.
The 16th edition of the Premis Junceda of the Associació Professional d’il·lustradors de Catalunya saw Miguel up against four other finalists for a prize in the ‘non-fiction book for adults or children’ section. The jury of illustrators is made up of winners of previous calls and personalities from the world of visual communication.
On Monday IBEC junior group leader Nuria Montserrat and senior researcher Aranzazu Villasante were two of the researchers awarded funding at the Asociación Española de Investigación sobre el Cáncer (AECC)’s ceremony in Madrid.
The AECC has bestowed 160 grants on cancer researchers during the past year, a total of €17.6m. The association made the official presentations of these awards at an event presided over by Her Majesty Queen Letizia on World Cancer Research Day, 24th September 2018.
A University of Barcelona master programme in which IBEC participates has been awarded the EIT Label, a certificate of quality for master and doctoral programmes, from EIT Health.
The Master of Technological Innovation in Health (MTIH), led by Sorbonne University, has achieved the EIT Label for its excellent scientific education coupled with innovation and entrepreneurship training. IBEC’s role in the degree programme includes the active participation of students, as well as the innovative technology for health being developed by IBEC’s researchers, many of whom teach on the programme.
Implemented by a consortium of five universities in France, Spain and Portugal, the MTIH provides ‘active learning’ methods and supports student mobility, and new teaching content is being added to strengthen students’ innovation and entrepreneurship expertise.
Eight IBECers were in the Netherlands on 13th and 14th September for the first ever IBEC-ICMS Symposium, ‘NanoSens&Med’.
The event aimed to identify synergies and potential for collaboration between IBEC groups and the researchers of the Institute for Complex Molecular Systems (ICMS), a research institute of the Eindhoven University of Technology (TU/e).
Two IBEC group leaders, Vito Conte and Lorenzo Albertazzi, already have dual appointments with ICMS. They opened the symposium by welcoming all participants from the two institutions and presented their research, as did Eduard Torrents, Elena Martinez, Silvia Muro, Nuria Montserrat, Samuel Sanchez and director Josep Samitier, who also introduced IBEC.
The start of the autumn semester finds a new face in IBEC’s research community, with Dr. Benedetta Bolognesi joining the institute as junior group leader.
Benedetta has come from Barcelona’s Centre for Genomic Regulation, where she was a postdoc in Ben Lehner’s and Gian Gaetano Tartaglia’s groups. At IBEC she will launch and lead the Protein Phase Transitions in Health and Disease group.
During her postdoc, Benedetta focused on why certain genes are toxic when over-expressed. She found that, in some cases, they cause toxicity because the proteins they code for end up forming a different liquid phase in the cytoplasm.
Today IBEC welcomed the new Director General of Research, Development, and Innovation of the Spanish Ministry of Science, Innovation and Universities (MINECO) to meet some of the group leaders and hear about their research.
Dr. Teresa Riesgo Alcaide met IBEC’s directors and was taken on a tour of the laboratories of Samuel Sánchez, Josep Samitier, Xavier Trepat and Elena Martínez, as well as viewing IBEC’s 3D bioprinting facilities.
Dr. Riesgo was in town for the EIT Health Partner Assembly at Caixa Forum, an important event on the calendar for the network.
IBEC is celebrating its sixth Caixaimpulse success, with Eduard Torrents’ project ‘BiofilmChip: personalized treatment for biofilm infections’ winning support in the programme’s fourth round.
Working in collaboration with Josep Samitier’s Nanobioengineering group, BiofilmChip will develop an easy-to-use device that allows biofilm-forming bacteria to be grown in vitro, enabling clinicians to evaluate the efficency of various antibiotics and determine the best individualized treatment for biofilm-infected patients. 20 projects from all over Spain and Portugal were awarded in this fourth round, selected from a total of 85 submissions.
More than thirty students from all over the world have arrived at the UPC Campus Diagonal-Besòs for the 11th Barcelona Cognition Brain and Technology summer school (BCBT2018), an annual event co-organised by IBEC’s SPECS group.
As in previous years, the summer school has invited top speakers in the fields of brain research, cognitive science, neuroscience, and artificial intelligence, including Tony Prescott from the University of Sheffield, who’s co-organiser of the event alongside SPECS group leader Paul Verschure and senior researcher Anna Mura. This year, the event is also supported by the Human Brain Project.
The European Commission has published its proposal for the next framework programme in research and innovation, Horizon Europe.
Succeeding Horizon 2020, Horizon Europe will run from 2021 to 2027 and aims to strengthen science and technology in the EU to help tackle the major global challenges of our time. The framework programme is based on the conviction that Europe’s success increasingly depends on its ability to transform excellent scientific results into innovation that will have a beneficial impact on the economy and quality of life, and create new markets with more skilled jobs.
IBEC is listed as an ‘outstanding’ Spanish research centre for Horizon 2020 funding in a recent report published by the Centro para el Desarrollo Tecnológico Industrial (CDTI).
The institute, which coordinates eight H2020 projects and is a partner in two more, appears in the table ‘20 asociaciones de investigación más destacadas por retorno en H2020’ (pictured) in the CDTI’s ‘Participación española en Horizonte 2020: Resultados provisionales (2014-2017)’. This report presents the facts and figures behind the participation of Spanish universities, research centres, companies and other organisations in the EU’s current framework programme, which took over from FP7 in 2014.